Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLLWoyach, Jennifer A ; Ruppert, Amy S ; Heerema, Nyla A ; Zhao, Weiqiang ; Booth, Allison M ; Ding, Wei ; Bartlett, Nancy L ; Brander, Danielle M ; Barr, Paul M ; Rogers, Kerry A ; Parikh, Sameer A ; Coutre, Steven ; Hurria, Arti ; Brown, Jennifer R ; Lozanski, Gerard ; Blachly, James S ; Ozer, Hatice G ; Major-Elechi, Brittny ; Fruth, Briant ; Nattam, Sreenivasa ; Larson, Richard A ; Erba, Harry ; Litzow, Mark ; Owen, Carolyn ; Kuzma, Charles ; Abramson, Jeremy S ; Little, Richard F ; Smith, Scott E ; Stone, Richard M ; Mandrekar, Sumithra J ; Byrd, John CThe New England journal of medicine, 2018-12, Vol.379 (26), p.2517-2528 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
|
2 |
Material Type: Artigo
|
Reliability of six prognostic models to predict time‐to‐first‐treatment in patients with chronic lymphocytic leukaemia in early phaseMolica, Stefano ; Giannarelli, Diana ; Mirabelli, Rosanna ; Levato, Luciano ; Gentile, Massimo ; Morabito, Fortunato ; Montserrat, EmiliAmerican journal of hematology, 2017-06, Vol.92 (6), p.E91-E93 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
3 |
Material Type: Artigo
|
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaBurger, Jan A ; Tedeschi, Alessandra ; Barr, Paul M ; Robak, Tadeusz ; Owen, Carolyn ; Ghia, Paolo ; Bairey, Osnat ; Hillmen, Peter ; Bartlett, Nancy L ; Li, Jianyong ; Simpson, David ; Grosicki, Sebastian ; Devereux, Stephen ; McCarthy, Helen ; Coutre, Steven ; Quach, Hang ; Gaidano, Gianluca ; Maslyak, Zvenyslava ; Stevens, Don A ; Janssens, Ann ; Offner, Fritz ; Mayer, Jiří ; O’Dwyer, Michael ; Hellmann, Andrzej ; Schuh, Anna ; Siddiqi, Tanya ; Polliack, Aaron ; Tam, Constantine S ; Suri, Deepali ; Cheng, Mei ; Clow, Fong ; Styles, Lori ; James, Danelle F ; Kipps, Thomas JThe New England journal of medicine, 2015-12, Vol.373 (25), p.2425-2437 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
|
4 |
Material Type: Artigo
|
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsiesTian, Sufang ; Xiong, Yong ; Liu, Huan ; Niu, Li ; Guo, Jianchun ; Liao, Meiyan ; Xiao, Shu-YuanModern pathology, 2020-06, Vol.33 (6), p.1007-1014 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
|
5 |
Material Type: Artigo
|
A CROSS‐SECTIONAL STUDY ON THE GLOBAL DIFFERENCES IN INFORMATION EXPERIENCES AND NEEDS OF PATIENTS WITH LYMPHOMA AND CLLWarwick, L. ; Bamigbola, O. ; Dren, N.Hematological oncology, 2021-06, Vol.39 (S2) [Periódico revisado por pares]Chichester: Wiley Subscription Services, IncTexto completo disponível |
|
6 |
Material Type: Artigo
|
THE CLL‐RT1 TRIAL: A MULTICENTER PHASE‐2 TRIAL OF ZANUBRUTINIB, A BTK INHIBITOR, PLUS TISLELIZUMAB, A PD‐1 INHIBITOR, FOR PATIENTS WITH RICHTER TRANSFORMATIONAl‐Sawaf, O. ; Robrecht, S. ; Stumpf, J. ; Fink, A.‐M. ; Ritgen, M. ; Johansson, P. ; Tausch, E. ; Hoechstetter, M. ; Staber, P. ; Jäger, U. ; Niemann, C. U. ; Pallasch, C. ; Kreuzer, K.‐A. ; Stilgenbauer, S. ; Fischer, K. ; Wendtner, C. ; Hallek, M. ; Eichhorst, B.Hematological oncology, 2021-06, Vol.39 (S2) [Periódico revisado por pares]Chichester: Wiley Subscription Services, IncTexto completo disponível |
|
7 |
Material Type: Artigo
|
TRANSCEND CLL 004: PHASE 1 COHORT OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) COMBINED WITH IBRUTINIB (IBR) FOR PATIENTS (PTS) WITH R/R CLL/SLLWierda, W. G. ; Dorritie, K. A. ; Munoz, J. ; Stephens, D. M. ; Solomon, S. ; Gillenwater, H. H. ; Gong, L. ; Yang, L. ; Ogasawara, K. ; Thorpe, J. ; Siddiqi, T.Hematological oncology, 2021-06, Vol.39 (S2) [Periódico revisado por pares]Chichester: Wiley Subscription Services, IncTexto completo disponível |
|
8 |
Material Type: Artigo
|
SAFETY AND EFFECTIVENESS OF VENETOCLAX MONOTHERAPY IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY CLL UNDER REAL‐LIFE CONDITIONS – DATA FROM THE OBSERVATIONAL STUDY VERVESchwaner, I. ; Hebart, H. ; Losem, C. ; Wolff, T. ; Huelsenbeck, J. ; Schmidt, B. ; Rossi, D. ; Noesslinger, T.Hematological oncology, 2021-06, Vol.39 (S2) [Periódico revisado por pares]Chichester: Wiley Subscription Services, IncTexto completo disponível |
|
9 |
Material Type: Artigo
|
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatmentHallek, MichaelAmerican journal of hematology, 2019-11, Vol.94 (11), p.1266-1287 [Periódico revisado por pares]Hoboken, USA: John Wiley & Sons, IncTexto completo disponível |
|
10 |
Material Type: Artigo
|
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemiaFraietta, Joseph A ; Lacey, Simon F ; Orlando, Elena J ; Pruteanu-Malinici, Iulian ; Gohil, Mercy ; Lundh, Stefan ; Boesteanu, Alina C ; Wang, Yan ; O'Connor, Roddy S ; Hwang, Wei-Ting ; Pequignot, Edward ; Ambrose, David E ; Zhang, Changfeng ; Wilcox, Nicholas ; Bedoya, Felipe ; Dorfmeier, Corin ; Chen, Fang ; Tian, Lifeng ; Parakandi, Harit ; Gupta, Minnal ; Young, Regina M ; Johnson, F Brad ; Kulikovskaya, Irina ; Liu, Li ; Xu, Jun ; Kassim, Sadik H ; Davis, Megan M ; Levine, Bruce L ; Frey, Noelle V ; Siegel, Donald L ; Huang, Alexander C ; Wherry, E John ; Bitter, Hans ; Brogdon, Jennifer L ; Porter, David L ; June, Carl H ; Melenhorst, J JosephNature medicine, 2018-05, Vol.24 (5), p.563-571 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |